These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 162005)
41. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation. Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157 [TBL] [Abstract][Full Text] [Related]
42. [Evaluation and significance of circulating immunocomplexes and their correlation with other immunologic parameters in connective tissue diseases]. Rodrigo MJ; Fonollosa V; Vilardell M; Codina R; Lience E; Schwartz S Med Clin (Barc); 1990 Sep; 95(7):241-6. PubMed ID: 2283896 [TBL] [Abstract][Full Text] [Related]
43. [Cryoglobulinemia and fibronectin in systemic lupus erythematosus]. Baranauskaĭte AA; Nasonov EL; Efremov EE; Kurmanova LV; Eremeeva MV; Solov'ev SK; Kovalev VIu; Lopaeva OV; Kobylianskiĭ AG Ter Arkh; 1991; 63(5):75-8. PubMed ID: 1887425 [TBL] [Abstract][Full Text] [Related]
45. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations]. Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165 [TBL] [Abstract][Full Text] [Related]
46. Circulating immune complexes in systemic lupus erythematosus. Cano PO; Jerry LM; Sladowski JP; Osterland CK Clin Exp Immunol; 1977 Aug; 29(2):197-204. PubMed ID: 302768 [TBL] [Abstract][Full Text] [Related]
48. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? van der Woude FJ; van der Giessen M; Kallenberg CG; Ouwehand W; Beekhuis H; Beelen JM; van Son WJ; Hoedemaeker PJ; van der Hem GK; The TH Clin Exp Immunol; 1984 Mar; 55(3):473-80. PubMed ID: 6584255 [TBL] [Abstract][Full Text] [Related]
49. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients. Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619 [TBL] [Abstract][Full Text] [Related]
50. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus. Yen JH; Liu HW; Lin SF; Chen JR; Chen TP J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256 [TBL] [Abstract][Full Text] [Related]
53. [Heterogeneity and etiological significance of anti-DNA antibody in systemic lupus erythematosus. Analysis of new DNA-anti DNA immune complexes in the circulatory blood]. Okuda M Nihon Rinsho; 1976; 34(4):738-45. PubMed ID: 133256 [No Abstract] [Full Text] [Related]
54. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. Lockwood CM; Worlledge S; Nicholas A; Cotton C; Peters DK N Engl J Med; 1979 Mar; 300(10):524-30. PubMed ID: 154062 [TBL] [Abstract][Full Text] [Related]